Oral complications during the two waves of COVID-19 pandemic in China: a prospective cross-section analysis of 510 cases using questionnaire.

Publication date: Oct 23, 2024

Oral complications such as parageusia, xerostomia, and oral ulcers are frequently observed in patients with COVID-19. The aim of this study was to understand the oral complications and their influencing factors during the two waves of the COVID-19 pandemic in China between December 2022 and May 2023. A total of 347 patients during the COVID-19 pandemic from December 2022 and January 2023 and 163 patients during the second COVID-19 pandemic were recruited through the Disease Prevention and Control Reporting System. Data on oral complications were collected via researcher-made questionnaires. During both pandemic periods, more than 50% of the subjects developed oral complications. Specifically, the incidence of parageusia, pathological tongue coating, and xerostomia all exceeded 20%, while the incidence of oral ulcers surpassed 7%. Patients with allotriosmia and xerostomia had a significantly higher likelihood of developing other oral complications. Hospitalized patients requiring supplemental oxygen had a significantly higher incidence of oral complications. The results of our study underline that oral complications during the COVID-19 pandemic are prevalent, and their incidence has not decreased during the subsequent pandemic. In the context of the ongoing global spread of COVID-19, this study lays the foundation for physicians in recognizing and managing oral complications, which will improve the oral health of communities globally.

Open Access PDF

Concepts Keywords
China Adolescent
December Adult
Pandemic Aged
Physicians China
COVID-19
COVID-19
Cross-Sectional Studies
Female
Humans
Incidence
Male
Middle Aged
Mouth Diseases
Oral complications
Oral Ulcer
Oral ulcer
Pandemics
Parageusia
Prospective Studies
Questionnaire
SARS-CoV-2
Surveys and Questionnaires
Xerostomia
Xerostomia
Young Adult

Semantics

Type Source Name
disease MESH complications
disease MESH COVID-19 pandemic
disease MESH parageusia
disease MESH xerostomia
disease MESH oral ulcers
drug DRUGBANK Oxygen
disease MESH oral health
disease MESH Long Covid
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease IDO pathogen
disease IDO replication
disease IDO immune response
disease MESH inflammation
disease IDO symptom
disease MESH infection
disease IDO infection incidence
drug DRUGBANK Methionine
disease IDO nucleic acid
drug DRUGBANK Medical air
disease MESH bleeding
disease MESH hyperemia
disease MESH Mouth Diseases

Original Article

(Visited 1 times, 1 visits today)